Search Results - "Bousley, Richard"

Substituted oxazolidinones as novel NPC1L1 ligands for the inhibition of cholesterol absorption by Pfefferkorn, Jeffrey A., Larsen, Scott D., Huis, Chad Van, Sorenson, Roderick, Barton, Tom, Winters, Thomas, Auerbach, Bruce, Wu, Chenyan, Wolfram, Thaddeus J., Cai, Hongliang, Welch, Kathleen, Esmaiel, Nadia, Davis, JoAnn, Bousley, Richard, Olsen, Karl, Mueller, Sandra Bak, Mertz, Thomas

“…This manuscript describes the synthesis and evaluation of a series of oxazolidinone-based NPC1L1 ligands for the inhibition of cholesterol absorption…”
Get full text

Heterocyclic Ureas:  Inhibitors of Acyl-CoA:Cholesterol O-Acyltransferase as Hypocholesterolemic Agents by White, Andrew D, Creswell, Mark W, Chucholowski, Alexander W, Blankley, C. John, Wilson, Michael W, Bousley, Richard F, Essenburg, Arnold D, Hamelehle, Katherine L, Krause, Brian R, Stanfield, Richard L, Dominick, Mark A, Neub, Martin

“…A series of diaryl-substituted heterocyclic ureas was prepared, and their ability to inhibit acyl-CoA:cholesterol O-acyltransferase (ACAT) in vitro and to…”
Get full text

Inhibitors of Acyl-CoA:Cholesterol O-Acyltransferase. 17. Structure−Activity Relationships of Several Series of Compounds Derived from N-Chlorosulfonyl Isocyanate by Picard, Joseph A, O'Brien, Patrick M, Sliskovic, Drago R, Anderson, Maureen K, Bousley, Richard F, Hamelehle, Katherine L, Krause, Brian R, Stanfield, Richard L

“…Several series of acyl-CoA:cholesterol O-acyltransferase inhibitors were prepared by the stepwise addition of nitrogen, oxygen, and sulfur nucleophiles to…”
Get full text

CI-1011 lowers lipoprotein(a) and plasma cholesterol concentrations in chow-fed cynomolgus monkeys by Ramharack, Randy, Spahr, Mark A, Sekerke, Catherine S, Stanfield, Richard L, Bousley, Richard F, Lee, Helen T, Krause, Brian K

“…Lipoprotein(a) (Lp(a)), which is generated through the covalent association of apolipoprotein(a) (apo(a)) and apo B-100-LDL, is an independent risk factor for…”
Get full text

Inhibitors of Acyl-CoA:Cholesterol Acyltransferase (ACAT). 7. Development of a Series of Substituted N-Phenyl-N'-[(1-phenylcyclopentyl)methyl]ureas with Enhanced Hypocholesterolemic Activity by Trivedi, Bharat K, Purchase, Terri Stoeber, Holmes, Ann, Augelli-Szafran, Corinne E, Essenburg, Arnold D, Hamelehle, Katherine L, Stanfield, Richard L, Bousley, Richard F, Krause, Brian R

“…We recently described our initial structure-activity relationship (SAR) studies on a series of N-phenyl-N'-aralkyl- and N-phenyl-N'-(1-phenylcycloalkyl)ureas…”
Get full text

α-Substituted Malonester Amides:  Tools To Define the Relationship between ACAT Inhibition and Adrenal Toxicity by Sliskovic, Drago R, Picard, Joseph A, O'Brien, Patrick M, Liao, Peggy, Roark, W. Howard, Roth, Bruce D, Anderson, Maureen A, Mueller, Sandra Bak, Bocan, Thomas M. A, Bousley, Richard F, Hamelehle, Katherine L, Homan, Reynold, Reindel, James F, Stanfield, Richard L, Turluck, Daniel, Krause, Brian R

“…We prepared a series of α-substituted malonester amides that were evaluated for their ability to inhibit acyl-CoA:cholesterol O-acyl transferase activity in…”
Get full text

Antithrombotic effect of LB-30057 (CI-1028), a new synthetic thrombin inhibitor, in a rabbit model of thrombosis: Comparison with inogatran by LIGUO CHI, MERTZ, Thomas E, ROGERS, Karen L, JANICZEK, Nancy, PENG, Yun-Wen, SAGANEK, Lori, BOUSLEY, Richard F, JUNEAU, Paul L, UPRICHARD, Andrew C. G, GALLAGHER, Kim P

“…LB-30057 (CI-1028) is a novel, orally bioavailable, direct thrombin inhibitor with a Ki of 0.38 nM against human thrombin. The effects of LB-30057 on thrombus…”
Get full text

Heterocyclic Amides:  Inhibitors of Acyl-CoA:Cholesterol O-Acyl Transferase with Hypocholesterolemic Activity in Several Species and Antiatherosclerotic Activity in the Rabbit by White, Andrew D, Purchase, Claude F, Picard, Joseph A, Anderson, Maureen K, Bak Mueller, Sandra, Bocan, Thomas M. A, Bousley, Richard F, Hamelehle, Katherine L, Krause, Brian R, Lee, Peter, Stanfield, Richard L, Reindel, James F

“…A series of heterocyclic amides were synthesized and evaluated as inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT) in vitro and for cholesterol…”
Get full text

Tetrazole-substituted ureas as inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT). A novel preparation of ureas from weakly nucleophilic amines by Purchase, Claude F, White, Andrew D, Anderson, Maureen K, Bocan, Thomas M.A, Bousley, Richard F, Hamelehle, Katherine L, Homan, Reynold, Krause, Brian R, Lee, Peter, Mueller, Sandra Bak, Speyer, Cecilia, Stanfield, Richard L, Reindel, James F

“…A novel series of tetrazole-substituted ureas 2 were prepared from weakly nucleophilic amines using a new coupling method. The ureas were found to potently…”
Get full text

Inhibitors of acyl-CoA:cholesterol acyltransferase. 5. Identification and structure-activity relationships of novel .beta.-keto amides as hypocholesterolemic agents by Augelli-Szafran, Corinne E, Blankley, C. John, Roth, Bruce D, Trivedi, Bharat K, Bousley, Richard F, Essenburg, Arnold D, Hamelehle, Katherine L, Krause, Brian R, Stanfield, Richard L

Get full text

Inhibitors of Acyl-CoA:Cholesterol O-Acyltransferase. 11. Structure-Activity Relationships of Several Series of Compounds Derived from N-(Chlorocarbonyl) Isocyanate by Picard, Joseph A, Bousley, Richard F, Lee, Helen T, Hamelehle, Katherine L, Krause, Brian R, Minton, Laura L, Sliskovic, Drago R, Stanfield, Richard L

“…Five series of compounds (4-9) derived from N-(chlorocarbonyl) isocyanate have been synthesized and evaluated for their ability to inhibit the enzyme…”
Get full text

Inhibitors of Acyl-CoA:cholesterol O-Acyl Transferase (ACAT) as Hypocholesterolemic Agents.6.The First Water-Soluble ACAT Inhibitor with Lipid-Regulating Activity by Sliskovic, Drago R, Krause, Brian R, Picard, Joseph A, Anderson, Maureen, Bousley, Richard F, Hamelehle, Katherine L, Homan, Reynold, Julian, Thomas N, Rashidbaigi, Zara A, Stanfield, Richard L

Get full text

Effect of the ACAT inhibitor CI-976 on plasma cholesterol concentrations and distribution in hamsters fed zero- and low-cholesterol diets by Krause, B R, Bousley, R F, Kieft, K A, Stanfield, R L

“…The overall objective of the present study was to determine if the ACAT inhibitor CI-976 can lower plasma cholesterol in hamsters fed zero or low, "human-like"…”
Get more information

Inhibitors of Acyl-CoA:Cholesterol O-Acyl Transferase (ACAT) as Hypocholesterolemic Agents. CI-1011:  An Acyl Sulfamate with Unique Cholesterol-Lowering Activity in Animals Fed Noncholesterol-Supplemented Diets by Lee, Helen T., Sliskovic, Drago R., Picard, Joseph A., Roth, Bruce D., Wierenga, Wendell, Hicks, James L., Bousley, Richard F., Hamelehle, Katherine L., Homan, Reynold, Speyer, Cecilia, Stanfield, Richard L., Krause, Brian R.

Get full text

Inhibitors of Acyl-CoA:Cholesterol O-Acyltransferase. Synthesis and Pharmacological Activity of (±)-2-Dodecyl-α-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5-acetamide and Structurally Related Tetrazole Amide Derivatives by O'Brien, Patrick M, Sliskovic, Drago R, Picard, Joseph A, Lee, Helen T, Purchase, Claude F, Roth, Bruce D, White, Andrew D, Anderson, Maureen, Mueller, Sandra Bak, Bocan, Thomas, Bousley, Richard, Hamelehle, Katherine L, Homan, Reynold, Lee, Peter, Krause, Brian R, Reindel, J. F, Turluck, Daniel

“…A series of tetrazole amide derivatives of (±)-2-dodecyl-α-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5-acetamide (1) was prepared and evaluated for their…”
Get full text

The antithrombotic effects of CI-1028, an orally bioavailable direct thrombin inhibitor, in a canine model of venous and arterial thrombosis by MCCLANAHAN, Thomas B, HICKS, Gary W, IGNASIAK, Diane P, BOUSLEY, Richard, MERTZ, Thomas E, JUNEAU, Paul, JANICZEK-DOLPHIN, Nancy, KIM, In-Chull, GALLAGHER, Kim P

“…Direct thrombin inhibitors represent a new class of drug that may offer a therapeutic alternative for the treatment and prevention of thrombembolic conditions,…”
Get full text

Inhibitors of acyl-CoA: cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 6. The first water-soluble ACAT inhibitor with lipid-regulating activity by Sliskovic, D R, Krause, B R, Picard, J A, Anderson, M, Bousley, R F, Hamelehle, K L, Homan, R, Julian, T N, Rashidbaigi, Z A, Stanfield, R L

Get full text

Effects of Intravenous Enoxaparin and Intravenous Inogatran in an Electrolytic Injury Model of Venous Thrombosis in the Dog by Ignasiak, DP, McClanahan, TB, Bousley, RE, Juneau, PL, Gallagher, KP

“…The objective of this study was to compare the effectiveness of the low molecular weight heparin, enoxaparin (Lovenox((R))), and inogatran (a direct thrombin…”
Get full text

Effects of Quinapril, a New Angiotensin Converting Enzyme Inhibitor, on Left Ventricular Failure and Survival in the Cardiomyopathic Hamster: Hemodynamic, Morphological, and Biochemical Correlates by Haleen, Stephen J, Weishaar, Ronald E, Overhiser, Ronald W, Bousley, Richard F, Keiser, Joan A, Rapundalo, Stephen R, Taylor, David G

“…The effect of chronic therapy with quinapril on the temporal progression of left ventricular failure and survival was assessed in the CHF 146 cardiomyopathic…”
Get full text

Inhibitors of acyl-CoA: Cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 13. Design, synthesis and biological evaluation of tetrazole anilides as potent inhibitors of ACAT in vitro and hypocholesterolemic agents in vivo by O'Brien, Patrick M., Sliskovic, Drago R., Bernabei, Adele, Hurley, Timothy, Anderson, Maureen K., Bousley, Richard F., Krause, Brian R., Stanfield, Richard L.

“…The syntheses and biological activities for anilides derived from 2-phenyl-2-(dodecyl-2H-tetrazol-5-yl)acetic acid are described. Evidence is provided that one…”
Get full text